The Nasdaq Biotechnology Index rose over 1% in early trading of U.S. stocks. Among the constituent stocks, Annexon rose 14.04%, Design Therapeutics rose 15.80%, Adaptive Biotechnologies rose 10.89%, Alumis rose 10.27%, and Agios Pharmaceuticals rose 9.44%. Biogen fell 0.97%, Amgen fell 1.28%, Applied Therapeutics fell 2.32%, and Arrowhead Pharmaceuticals fell 2.79%Wallstreetcn·Nov 20, 2025 at 02:41 PMDSGN-2.48%ADPT+3.79%
